Analyzing...
Transcript of Conference call with Analysts / Investors on Financial Results for the quarter and nine months ended 31st December, 2023 In continuation of our letter dated 22-Jan-24 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Transcript of Conference call with Analysts / Investors on Financial Results of the Company for the quarter and nine months ended https://www.torrentpharma.com/pdf/investors/TorrentPharma_Earnings_Q3_2023_24.pdf Kindly take note of the above.
Thanking you,